Italfarmaco Provides Givinostat Update (March 2019) Italfarmaco joined PPMD for a webinar on March 27, 2019 to update the community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 6 years ago You may also like 36:52 Rolling Around the World (June 2019) 5 years ago For Teens & Adults,PPMD Adult Advisory Committee (PAAC) Webinars,Webinars 56:20 Domagrozumab as a Potential Treatment for Duchenne (May 2019) 5 years ago Research & Clinical Trial Webinars,Webinars 55:59 Santhera Update to the Duchenne Community (May 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 34:57 Capricor’s Clinical Program (April 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 1:00:47 Caring for the Caregiver (February 2019) 6 years ago Care Webinars,Webinars 59:40 Vamorolone Clinical Trials in Duchenne (January 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 44:17 Translarna® (ataluren) Development Update (January 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 1:04:43 The Heart of the Matter – PPMD’s Research Priorities (December 2018) 6 years ago Research & Clinical Trial Webinars,Webinars «1…1314151617…25»Page 15 of 25
by: Parent Project Muscular Dystrophy
